BIAF
bioAffinity Technologies, Inc.
NASDAQ: BIAF · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.49
+2.26% today
Updated 2026-04-30
Market cap
$10.03M
P/E ratio
—
P/S ratio
1.63x
EPS (TTM)
$-8.66
Dividend yield
—
52W range
$1 – $15
Volume
10.8M
bioAffinity Technologies, Inc. (BIAF) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-242.00%
Operating margin
-197.00%
ROE
-301.80%
ROA
-75.60%
Debt/equity
0.08x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-3.31M | — | — | — |
| 2020 | $0.00 | $-7.27M | — | — | — |
| 2021 | $1306.00 | $-6.33M | -368.84% | -168,975.65% | -484,411.41% |
| 2022 | $4803.00 | $-8.15M | 90.28% | -83,511.51% | -169,771.25% |
| 2023 | $2.53M | $-7.94M | 31.26% | -314.89% | -313.47% |
| 2024 | $9.36M | $-9.04M | 36.09% | -95.63% | -96.56% |
| 2025 | $6.16M | $-14.91M | 23.21% | -171.58% | -241.96% |